Rafferty Asset Management’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$512K Buy
+282,902
New +$489K ﹤0.01% 888
2024
Q4
Sell
-797,331
Closed -$791K 1166
2024
Q3
$791K Sell
797,331
-279,711
-26% -$384K ﹤0.01% 847
2024
Q2
$1.67M Buy
+1,077,042
New +$1.68M 0.01% 696
2023
Q1
Sell
-2,471,170
Closed -$3.21M 1160
2022
Q4
$3.21M Buy
2,471,170
+537,263
+28% +$837K 0.03% 469
2022
Q3
$3.44M Buy
1,933,907
+548,173
+40% +$1.36M 0.04% 393
2022
Q2
$3.15M Sell
1,385,734
-796,766
-37% -$1.91M 0.03% 381
2022
Q1
$7.2M Buy
2,182,500
+1,196,855
+121% +$4.21M 0.04% 260
2021
Q4
$4.49M Buy
985,645
+549,841
+126% +$4.15M 0.02% 424
2021
Q3
$3.13M Buy
435,804
+24,371
+6% +$179K 0.02% 452
2021
Q2
$3.3M Buy
411,433
+78,252
+23% +$660K 0.02% 480
2021
Q1
$2.26M Buy
+333,181
New +$2.22M 0.02% 586

Other funds holding OCGN

Rafferty Asset Management's OCGN Position: Q1 2026 in Review

Rafferty Asset Management opened a new position in Ocugen (OCGN) in Q1 2026: 282,902 shares worth $512K. The stake represents ﹤0.01% of the portfolio and ranks #888 among its holdings. This is a return to the name: Rafferty Asset Management previously reported a position in OCGN as recently as Q3 2024.

Rafferty Asset Management first reported a position in OCGN in Q1 2021 and has held it in 11 quarters since. The position peaked at $7.2M in Q1 2022. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Rafferty Asset Management held 282,902 shares of Ocugen worth $512K as of Q1 2026.
  • Ocugen was a new Rafferty Asset Management position in Q1 2026.
  • Ocugen made up ﹤0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #888 holding.
  • Rafferty Asset Management first reported a position in Ocugen in Q1 2021 and has held it in 11 quarters since.
  • Rafferty Asset Management's Ocugen position peaked at $7.2M in Q1 2022.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.